(Q35348860)

7 August 2017

1 reference

title

Cholecystolithiasis: lithotherapy for the 1990s (English)

1 reference

7 August 2017

S. M. Strasberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387104

21 September 2022

P. A. Clavien

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387104

21 September 2022

language of work or name

English

0 references

publication date

1 September 1992

1 reference

7 August 2017

1 reference

7 August 2017

volume

16

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

820-839

1 reference

The natural history of cholelithiasis: the National Cooperative Gallstone Study.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Carcinoma in the Porcelain Gallbladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Outcome of acute cholecystitis in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Acute cholecystitis in the diabetic. A case-control study of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Acute cholecystitis occurring as a complication of other diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

The distinction between cost and charges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Predicting gallstone composition with CT: in vivo and in vitro analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

The Munich Gallbladder Lithotripsy Study. Results of the first 5 years with 711 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Extracorporeal shock wave lithotripsy of gallbladder stones: a pessimistic view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Physical characteristics of gallstones removed at cholecystectomy: implications for extracorporeal shock-wave lithotripsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Biliary tract operations. A review of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Ambulatory cholecystectomy without disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Discharge within 24 hours of elective cholecystectomy. The first 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

Risk factors for the development of cholelithiasis in man (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Socioeconomic status and the prevalence of clinical gallbladder disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

A population study on the prevalence of gallstone disease: the Sirmione Study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Prevalence of gallstones in a Norwegian population

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Symptomatic and silent gall stones in the community

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Longitudinal study of gall stone prevalence at necropsy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Remarks on Cholecystotomy in Dropsy of the Gall-Bladder

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The Frequency and Future of Gallstones Believed to be Quiescent or Symptomless

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Surgical indications in cholelithiasis: prophylactic choleithiasis: prophylactic cholecystectomy elucidated on the basis of long-term follow up on 526 nonoperated cases.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Surgical indications in patients with silent gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.1840160332

1 reference

7 January 2021

The silent gallstone; a 10- to 20 year follow-up study of 112 cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The natural history of silent gallstones: the innocent gallstone is not a myth.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Prevalence of gallstone disease in a general population of Okinawa, Japan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Prevalence of gall stones in Dundee: a necropsy study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gall stones and mortality: a study of all gall stone related deaths in a single health district

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Abdominal symptoms and gallstone disease: An epidemiological investigation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Chronology of cholelithiasis. Dating gallstones from atmospheric radiocarbon produced by nuclear bomb explosions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The risk ratio is insufficient for clinical decisions. The case of prophylactic cholecystectomy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Lithotripsy versus cholecystectomy for management of gallstones. A decision analysis by Markov process.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gallstone growth, size, and risk of gallbladder cancer: an interracial study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Carcinoma of the gallbladder in a population of Southwestern American Indians.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Asymptomatic gallstones. Does diabetes mellitus make a difference?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Asymptomatic gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gallstones and diabetes: an ominous association

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cholecystitis and Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Deaths from gallstones. Incidence and associated clinical factors.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Influence of diabetes mellitus on operative risk

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Acute cholecystitis as a postoperative complication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Management of cholelithiasis in patients with abdominal aortic aneurysm.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Operative management of incidental cholelithiasis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Incidental cholecystectomy during major abdominal surgery in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Biliary tract surgery concomitant with other intra-abdominal operations.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Risk of additional intra-abdominal procedures at the time of colectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Associated intra-abdominal lesions encountered during resection of aortic aneurysms: surgical considerations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Combining intra-abdominal arterial grafting with gastrointestinal or biliary tract procedures.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Increased morbidity in surgical patients undergoing secondary (incidental) cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gall-bladder dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

A SURVEY OF FOOD INTOLERANCES IN HOSPITALIZED PATIENTS

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Some clinical observations on patients with gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Postcholecystectomy symptoms. A prospective study of gall stone patients before and two years after surgery.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Discriminant value of dyspeptic symptoms: a study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Influence of cholecystectomy on symptoms.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Evaluation of duodenogastric reflux in gallstone disease before and after simple cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Irritable bowel syndrome (IBS)--definition and pathophysiology.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Persistence of symptoms after gall bladder clearance with cholecystolithotripsy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Sequelae of cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones. The Dornier National Biliary Lithotripsy Study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

ESWL and gallstone dissolution with MTBE via a naso-vesicular catheter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gallstone dissolution with methyl tert-butyl ether in 120 patients--efficacy and safety.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Combined treatment of symptomatic gallbladder stones by extracorporeal shock-wave lithotripsy (ESWL) and instillation of methyl tert-butyl ether (MTBE)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

ERCG: endoscopic retrograde catheterization of the gallbladder

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Shattuck Lecture--the health care industry: where is it taking us?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Shattuck lecture--outcomes management. A technology of patient experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Effectiveness in Health Care

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The new technology assessment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Medical management of gallstones: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The utility of different health states as perceived by the general public

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.1840160332

1 reference

7 January 2021

Management of patients with symptomatic gallstones: a quantitative analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Fallacy of the five-year survival in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Symptom status and quality of life following prostatectomy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Restraint urged for biliary lithotripsy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Effect of Oral Chenodeoxycholic Acid on Bile Acid Kinetics and Biliary Lipid Composition in Women with Cholelithiasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Dissolution of cholesterol gallstones by ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Oral cholelitholysis--cheno versus urso: Japanese experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Ursodeoxycholic acid for the dissolution of radiolucent gall bladder stones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Optimum bile acid treatment for rapid gall stone dissolution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Chenotherapy for gallstone dissolution. I. Efficacy and safety

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The Sunnybrook Gallstone Study: a double-blind controlled trial of chenodeoxycholic acid for gallstone dissolution.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Computed tomographic analysis of gallstones. An in vitro study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Agents for gallstone dissolution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Dissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Is recurrence inevitable after gallstone dissolution by bile-acid treatment?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Low-Dose Chenodiol to Prevent Gallstone Recurrence After Dissolution Therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Aspirin prevention of cholesterol gallstone formation in prairie dogs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Simvastatin and ursodeoxycholic acid for rapid gallstone dissolution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

ESWL for bile duct stones: making waves in established therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Fragmentation of gallstones by extracorporeal shock waves.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Piezoelectric lithotripsy: stone disintegration and follow-up results in patients with symptomatic gallbladder stones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Treatment of gallstones with piezoelectric lithotripsy and oral bile acids. A multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Extracorporeal cholecystolithotripsy without oral chemolitholysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Aggressive extracorporeal shock wave lithotripsy of gall bladder stones within wider treatment criteria: fragmentation rate and early results

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Shock-wave lithotripsy of gallbladder stones. The first 175 patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Fragmentation of gallstones using extracorporeal shock waves: an in vitro study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Early gallstone recurrence rate after successful shock-wave therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

28,621 cholecystectomies in Ohio. Results of a survey in Ohio hospitals by the Gallbladder Survey Committee, Ohio Chapter, American College of Surgeons.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cholecystectomy and gallbladder conservation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The alkaline shift in gastric pH after cholecystectomy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Idiopathic bile acid catharsis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Gallbladder motility before and after extracorporeal shock-wave lithotripsy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Relationship between cholecystectomy and ascending colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cholecystectomy and carcinoma of the colon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Increased Risk of Colorectal Cancer After Cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cholecystectomy and carcinoma of the colon. An experimental study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cholecystectomy and the incidence of cancer of the large bowel.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Adenomas of the large bowel after cholecystectomy. A case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

A prospective analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Laparoscopic cholecystectomy. Experience with 375 consecutive patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Coelioscopic cholecystectomy. Preliminary report of 36 cases.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Elective laparoscopic cholecystectomy for "all-comers"

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Bile duct injury following laparoscopic cholecystectomy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Mechanisms of major biliary injury during laparoscopic cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Laparoscopic injuries to the bile duct. A cause for concern

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Bile duct injury during laparoscopic cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Avoidance of bile duct injury during laparoscopic cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Laparoscopic cholecystectomy: The dundee technique

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The economic burden of gallstone lithotripsy. Will cost determine its fate?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

The incidence and causes of death following surgery for nonmalignant biliary tract disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Cholecystectomy in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Early postoperative mortality following cholecystectomy in the entire female population of Denmark, 1977-1981.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Outpatient laparoscopic laser cholecystectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Reduced postoperative hospitalization after laparoscopic cholecystectomy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Conventional versus laparoscopic cholecystectomy and the randomized controlled trial. Cholecystectomy Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Controlled study of the effect of nicardipine and ceruletide on the sphincter of Oddi

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Meconium ileus: A review 1972–1990

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160332

7 January 2021

Identifiers

DOI

10.1002/HEP.1840160332

1 reference

7 August 2017

1 reference